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OBJECTIVES We tried to record an epicardial electrogram directly, and we examined local electrograms
before and after administration of a class IC anti-arrhythmic drug in patients with the
Brugada syndrome.
BACKGROUND Electrical heterogeneity of the epicardium in the right ventricular outflow tract (RVOT) has
been thought to be related to the Brugada syndrome. However, an epicardial abnormality has
not been demonstrated in patients with the Brugada syndrome.
METHODS In five patients with a Brugada-type electrocardiogram (ECG), local unipolar electrograms
were recorded at the epicardium and endocardium of the RVOT. To record the epicardial
electrogram directly, we introduced an electrical guidewire into the conus branch (CB) of the
right coronary artery. The duration of the local electrogram after termination of the QRS
complex (DP) was measured before and after class IC anti-arrhythmic drug administration.
The signal-averaged electrocardiogram (SAECG) was also obtained in all patients.
RESULTS A definite DP was observed at the epicardium, but not at the endocardium. After
administration of a class IC anti-arrhythmic drug, the DP at the epicardium was prolonged
from 38  10 ms to 67  24 ms. The late potential corresponding to the DP at the
epicardium was observed in all patients on the SAECG.
CONCLUSIONS An epicardial electrogram can be recorded from the CB. Recording from the CB enables
identification of an epicardial abnormality in patients with the Brugada syndrome. These
abnormal electrograms may be related to a myocardial abnormality in the epicardium of
patients with the Brugada syndrome. (J Am Coll Cardiol 2002;39:1992–5) © 2002 by the
American College of Cardiology Foundation
The Brugada syndrome is an idiopathic ventricular fibrilla-
tion (VF) characterized by ST-segment elevation in the
precordial leads, and is augmented by sodium channel
blockers (1–3). It has been suggested that electrical hetero-
geneity, especially at the epicardium of the right ventricle,
causes the ST-segment elevation and is related to the
occurrence of polymorphic ventricular arrhythmias (4,5).
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However, studies using body surface mapping or the signal-
averaged electrocardiogram (SAECG) have suggested that a
conduction delay exists in the anterior wall of the right
ventricle or the right ventricular outflow tract (RVOT) in
patients with the Brugada syndrome (6,7). However, endo-
cardial mapping in a routine electrophysiologic study failed
to demonstrate this electrical abnormality.
The conus branch (CB) arises at the right coronary
ostium or within the first few millimeters of the right
coronary artery. It runs on the surface of the free wall of the
right ventricular outflow tract (RVOT-FW). Therefore, an
electrogram obtained at the CB may reflect an epicardial
electrogram at the RVOT-FW. In this study, we analyzed
electrograms recorded at the CB and examined the effects of
class IC anti-arrhythmic drugs in patients with the Brugada
syndrome.
METHODS
Study group. Five male patients (age 45  11 years) with
the Brugada syndrome were studied. All patients had
persistent ST-segment elevation in the precordial leads. In
three patients, episodes of VF or aborted sudden cardiac
death were observed (i.e., symptomatic patients). In the
other two patients, no episodes of VF or aborted sudden
cardiac death were observed, but VF was demonstrated with
single or double extrastimulation at the RVOT-FW in the
electrophysiologic study (i.e., asymptomatic patients). Rou-
tine studies, including cardiac echocardiography, coronary
angiography, right and left ventriculography, radionucleog-
raphy and endomyocardial biopsy, showed no evidence of
structural heart disease.
Electrophysiologic study. After obtaining written, in-
formed consent, an electrophysiologic study was performed
in all patients.
After right coronary arteriography, an electrical guidewire
(FloWire, Cardiometrics, California) was introduced into
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the CB through the right coronary artery. A local unipolar
electrogram at the epicardium of the RVOT-FW was
recorded at the tip of the wire, using a 30- to 400-Hz
bandwidth. A local unipolar electrogram at the endocar-
dium was recorded using a 30- to 400-Hz bandwidth, by a
quadripolar 6F deflectable catheter positioned at the endo-
cardium at the RVOT-FW (Fig. 1A).
The duration of the local electrogram after termination of
the QRS complex (DP) was measured before and after class
IC anti-arrhythmic drug administration. Termination of
the QRS complex was defined in lead V5. Pilsicainide (0.7
to 1.0 mg/kg) was administered to Patients 1 to 4, and
flecainide (1.0 mg/kg) was administered to Patient 5 as a
bolus over a period of 10 min.
SAECG. The SAECG (ART 1200EPX; noise level
0.3 V, high-pass filtering of 40 Hz using a bidirectional
four-pole Butterworth) was performed in all patients. The
filtered QRS duration, the root mean square voltage of the
terminal 40 ms in the filtered QRS complex (RMS40) and
the duration of low-amplitude signals 40 V in the
terminal filtered QRS complex (LAS40), were measured
Abbreviations and Acronyms
CB  conus branch
DP  local electrogram after termination of the
QRS complex
ECG  electrocardiogram/electrocardiographic
LAS40  duration of low-amplitude signals 40 V
in the terminal filtered QRS complex
LP  late potential
RMS40  root mean square voltage of the terminal
40 ms in the filtered QRS complex
RVOT  right ventricular outflow tract
RVOT-FW  free wall of the right ventricular outflow
tract
SAECG  signal-averaged electrocardiogram
VF  ventricular fibrillation
Figure 1. (A) Fluoroscopic 30° right anterior oblique (RAO) and 60° left anterior oblique (LAO) views of the position of the electrical guidewire introduced
into the conus branch through the right coronary artery for epicardial mapping (Epi), as well as the quadripolar deflectable catheter at the endocardium
of the free wall at the right ventricular outflow tract for endocardial mapping (Endo). (B) Surface electrocardiographic leads V1, V2 and V5 and intracardiac
electrograms of the epicardium (Epi) and endocardium (Endo) at the free wall at the right ventricular outflow tract before (Pre) and after (Post) the
administration of a class IC anti-arrhythmic drug in Patient 1 (asymptomatic patient). A definite local electrogram was recorded after termination of the
QRS complex at the epicardium (arrows), and the duration of the local electrogram after termination of the QRS complex after class IC anti-arrhythmic
drug administration was more prolonged at the epicardium than at the endocardium in Patient 1.
1993JACC Vol. 39, No. 12, 2002 Nagase et al.
June 19, 2002:1992–5 Epicardial Electrogram in the Brugada Syndrome
with SAECG. A late potential (LP) was considered to be
positive when two criteria (RMS40 20 V and LAS40
40 ms) were met.
RESULTS
A definite DP was observed at the epicardium, but not at
the endocardium. After administration of a class IC anti-
arrhythmic drug, the duration of the DP at the epicardium
was prolonged from 38  10 ms to 67  24 ms (Fig. 1B).
An LP corresponding to the DP at the epicardium was
observed in all patients on the SAECG (Fig. 2).
DISCUSSION
The Brugada syndrome is an idiopathic VF of uncertain
etiology (1–3). Several studies have suggested that electrical
heterogeneity is related to the genesis of the Brugada
syndrome (4,5). A depressed right ventricular epicardial
action potential dome is the basis for the ST-segment
elevation and leads to phase 2 re-entry as a trigger for
episodes of polymorphic ventricular arrhythmias. However,
the existence of a conduction delay at the RVOT has been
suggested in many reports (6,7). In addition, several clinical
studies have suggested that spontaneous episodes of VF are
triggered by premature ventricular contractions originating
from the right ventricular free wall (8,9). However, this
electrical abnormality was not demonstrated by endocardial
mapping in a routine electrophysiologic study.
In patients with the Brugada syndrome, class IC anti-
arrhythmic drug administration could augment ST-segment
elevation in the precordial leads, and spontaneous VF has
sometimes been observed (3,10).
The CB arises at the right coronary ostium or within the
first few millimeters of the right coronary artery. It runs on
the surface of the RVOT-FW. In this study, we were able
to directly record a unipolar epicardial electrogram at the
RVOT-FW, by using an electrical guidewire introduced
into the CB. There was a delayed potential at the QRS
complex in the epicardium of the RVOT-FW, which was
not demonstrated by endocardial mapping. Class IC anti-
Figure 2. (A to E) Surface electrocardiographic leads V2 and V5, intracardiac electrograms of the epicardium (Epi) at the free wall at the right ventricular
outflow tract and signal-averaged electrocardiogram (SAECG) in Patients 1 (A), 2 (B), 3 (C), 4 (D) and 5 (E). Patients 1 and 2 are asymptomatic patients,
and Patients 3, 4 and 5 are symptomatic patients. The late potentials, represented by the shaded area, are positive in all patients, showing the root mean
square voltage of the terminal 40 ms in the filtered QRS complex (RMS40) 20 V and the duration of low-ampltitude signals 40 V in the terminal
filtered QRS complex (LAS40) 40 ms, and correspond to a delayed potential after the QRS complex at the epicardium (arrows) in all patients. f-QRS 
filtered QRS duration.
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arrhythmic drug administration augmented ST-segment
elevation and also augmented the DP in the epicardium. An
LP was observed on the SAECG in all patients and
corresponded to the DP recorded on the epicardial electro-
gram. These abnormal electrograms were thought to reflect
a myocardial abnormality in the epicardium.
Because the CB is attached to the left ventricular cavity
through the low resistance of blood, it is quite possible that
the DP recorded in the CB reflects not only local electro-
grams at the RVOT, but also remote regions such as the left
ventricle. To exclude that possibility, left ventricular endo-
cardial mapping was performed in all patients, and the DP
was not demonstrated at the left ventricular endocardium in
any of the patients. Furthermore, left ventricular epicardial
electrograms of the great cardiac vein through the coronary
sinus were recorded in some patients who did not show a
DP.
Conclusions. Recording from the CB enables identifica-
tion of an epicardial abnormality in patients with the
Brugada syndrome. Class IC anti-arrhythmic drug admin-
istration worsens these abnormalities, which may play an
important role in the occurrence of VF in patients with the
Brugada syndrome.
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